QIAGEN NV
QGENF
QGENF was delisted on the 14th of February, 2005.
158 hedge funds and large institutions have $3.19B invested in QIAGEN NV in 2014 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 47 increasing their positions, 65 reducing their positions, and 30 closing their positions.
1,339% more call options, than puts
Call options by funds: $16.1M | Put options by funds: $1.12M
40% more capital invested
Capital invested by funds: $2.27B → $3.19B (+$918M)
5% less funds holding
Funds holding: 166 → 158 (-8)
27% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 30
28% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 65
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
Top Sellers
| 1 |
MNA
Manning & Napier Advisors
Fairport,
New York
|
-$52.7M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$23.1M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$22M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$17.8M |
| 5 |
Renaissance Technologies
New York
|
-$16M |
QGENF Hedge Fund Activity: Q2 2014 in Review
158 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in QIAGEN NV (QGENF) for Q2 2014, worth a combined $3.19B — up 40% from $2.27B a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of QGENF and 22 opened new positions — a net loss of 8 holders — while 65 trimmed existing stakes and 47 added.
The largest buyer was Franklin Resources, opening a new position worth an estimated $383M. The largest seller was Manning & Napier Advisors, cutting an estimated $52.7M.
- 158 institutional investors held QIAGEN NV (QGENF) as of Q2 2014, down from 166 in Q1 2014.
- Funds reported $3.19B of QIAGEN NV stock for Q2 2014, up 40% quarter-over-quarter.
- 22 funds opened new QIAGEN NV positions in Q2 2014 and 30 closed out, a net change of -8 holders.
- The largest QIAGEN NV buyer in Q2 2014 was Franklin Resources, an estimated $383M added.
- The largest QIAGEN NV seller in Q2 2014 was Manning & Napier Advisors, an estimated $52.7M sold.
Based on aggregated 13F filings for Q2 2014.